Zobrazeno 1 - 10
of 79
pro vyhledávání: '"M DeSilvio"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
K. Fizazi, R. Flippot, M.J. Morris, J. De Bono, K.N. Chi, K. Herrmann, K. Rahbar, S.T. Tagawa, L.T. Nordquist, N. Vaishampayan, G. El-Haddad, C.H. Park, T.M. Beer, W.J. Pérez-Contreras, M. DeSilvio, E. Kpamegan, G. Gericke, R.A. Messmann, B.J. Krause, O. Sartor
Publikováno v:
Médecine Nucléaire. 46:50-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a2dab586009f4970d8c8007e9916a62
https://doi.org/10.1016/j.mednuc.2022.01.006
https://doi.org/10.1016/j.mednuc.2022.01.006
Autor:
K. Fizazi, R. Flippot, K. Hermann, B.J. Krause, K. Rahbar, K.N. Chi, M.J. Morris, O. Sartor, S.T. Tagawa, A.T. Kendi, N. Vogelzang, J. Calais, J. Nagarajah, X.X. Wei, V.S. Koshkin, J.M. Beauregard, B. Chang, M. DeSilvio, R.A. Messmann, J. de Bono
Publikováno v:
Médecine Nucléaire. 46:51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bdcce92bfd9893a9d774e21ad05c04f
https://doi.org/10.1016/j.mednuc.2022.01.007
https://doi.org/10.1016/j.mednuc.2022.01.007
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michel Marty, Véronique Diéras, M. Lau, Howard A. Burris, M. DeSilvio, John Crown, M. Espie, P. Tresca, D. Kothari, M.J. Kennedy, Kevin M. Koch
Publikováno v:
Annals of Oncology. 24:2005-2011
Background This phase IB, open-label, dose-escalation study evaluated the safety, tolerability, and optimally tolerated regimen (OTR) of lapatinib in combination with docetaxel and trastuzumab in patients with previously untreated stage IV metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294ec3526658fd8f672843fdc66defeb
https://doi.org/10.1093/annonc/mdt222
https://doi.org/10.1093/annonc/mdt222
Autor:
W Arpornwirat, L Wang, Z. Shen, V Lorvidhaya, Y. Moore, Z-s Tong, B-h Xu, B. Newstat, Z-z Guan, M DeSilvio
Publikováno v:
Cancer Research. 70:P3-14
Background: Lapatinib (L) is a potent, oral selective, reversible, inhibitor of EGFR (ErbB1) and HER2 (ErbB2) receptor tyrosine kinases. EGF104535 is a phase III, international, randomized, double-blind study comparing lapatinib plus paclitaxel (L+P)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5bdce9a26d03af920a41ee9d971e384
https://doi.org/10.1158/0008-5472.sabcs10-p3-14-24
https://doi.org/10.1158/0008-5472.sabcs10-p3-14-24
Autor:
M. DeSilvio, Charles R. Thomas, M. Rotman, Sucha O. Asbell, Seunggu J. Han, Richard K. Valicenti, C. Lawton, Mitchell Machtay, Valery Uhl, Mack Roach, M. J. Seider, W. S. Shipley, C. Jones
Publikováno v:
Journal of Clinical Oncology. 21:1904-1911
Purpose: This trial tested the hypothesis that combined androgen suppression (CAS) and whole-pelvic (WP) radiotherapy (RT) followed by a boost to the prostate improves progression-free survival (PFS) by 10% compared with CAS and prostate-only (PO) RT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab4ac23c492769d152c68572fdd53926
https://doi.org/10.1200/jco.2003.05.004
https://doi.org/10.1200/jco.2003.05.004
Publikováno v:
Omega. 24:425-441
In response to an increasingly global and competitive environment, reengineering of fundamental cross functional processes is being actively pursued by corporations. This is particularly true in those industries which evolve rapidly. The flexibility
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6f6bad65532364ade50026fb700d16c
https://doi.org/10.1016/0305-0483(96)00007-2
https://doi.org/10.1016/0305-0483(96)00007-2
Autor:
H, Sandler, W U, Shipley, L, Gomella, K, Pienta, R H, Bard, D, Bruner, R, Clark, M, DeSilvio, L, Gaspar, M, Gillin, D, Grignon, E, Hammond, G, Hanks, K H, Heydon, D S, Kaufman, W R, Lee, J, Michalski, J, Mydlo, T, Pisansky, A, Pollack, H, Porterfield, M, Rifkin, M, Roach, M, Sanda, L, True, S, Vijayakumar, K A, Winter, A, Zeitman
Publikováno v:
International journal of radiation oncology, biology, physics. 51(3 Suppl 2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d4484c58b87389f0f951e6bf6c319acf
https://pubmed.ncbi.nlm.nih.gov/11641012
https://pubmed.ncbi.nlm.nih.gov/11641012
Autor:
W HARTSELL, M DESILVIO, D BRUNER, C SCARANTINO, R IVKER, M ROACH, J SUH, M SEIDER, B MOVSAS, I PETERSEN
Publikováno v:
International Journal of Radiation OncologyBiologyPhysics. 60:S143-S144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b8143997eb8336376bcfbc5ddbb1294
https://doi.org/10.1016/s0360-3016(04)01108-3
https://doi.org/10.1016/s0360-3016(04)01108-3